CClinicalTrials.gg
CompletedNCT06292130Updated May 16, 2025Results posted

Health-Kit Enabled Mobile App for Tobacco Cessation

An interventional study of refresh in Cigarette Smoking, sponsored by Pro-Change Behavior Systems. Completed at 1 site in United States. Open to participants aged 18 Years and older, including healthy volunteers. Per ClinicalTrials.gov, last updated 2025-05-16.

Sponsored by Pro-Change Behavior Systems · Not applicable, Interventional, and Treatment

Phase
Not applicable
Study type
Interventional
Enrollment
51
Allocation
Not applicable
Ages
18 Years and older
Sex
All
01

Study summary

Tobacco use is the leading preventable cause of death in the US, contributing to more than 480,000 premature deaths each year. The Tobacco Treatment Guidelines underscore the need to offer patients who use tobacco products brief interventions that include prescriptions for proven pharmacological smoking cessation aids and proactive connections to evidence-based behavioral support. The rapid expansion of smart phone capabilities enhances the potential for tobacco cessation apps to personalize behavior change guidance and to send contextually relevant tailored behavior change nudges based on readiness to quit and electronic heath record (EHR) data. Rich data from EHRs are now available to third-party apps from the Health app (iOS) via Fast Healthcare Interoperability Resources standard Application Programming Interface (API).

This Phase I Small Business Innovation Research (SBIR) explored the effects of one such innovative health IT solution. refresh is a highly individualized tobacco cessation HealthKit enabled app that 1) implemented a full range of best practices in tailored health behavior change communications based on readiness to change; 2) provided individualized behavior change guidance based on Health app data; and 3) concisely provided data and documentation of key actionable insights in the EHR on the patient's smoking status, app usage, and brief micro-message delivered by clinicians to reinforce and accelerate a patient's behavior change progress. This interoperability provided value to both patients and clinicians; empowered and supported successful and lasting behavior change; and enabled the implementation and evaluation of a best-in-class approach to tobacco and nicotine treatment.

Extensive end user and stakeholder input ensured that refresh was designed for rapid dissemination. Patients of an integrated delivery system with an upcoming appointment (n=51) were recruited to participate in a 30-day pilot test. Pre-post comparisons of Patient-Reported Outcomes Measurement Information System (PROMIS) measure for tobacco (psychosocial expectancies) and confidence for quitting provided preliminary data on the effects of the program. The hypothesis was that the patients who utilize refresh will have significantly higher psychosocial expectancies regarding tobacco at follow-up and greater confidence to quit smoking.

02

Conditions studied

  • Cigarette Smoking

Keywords

  • smoking
  • app
03

In context

Lead sponsor

Pro-Change Behavior Systems is the lead sponsor of 16 studies on the registry; none are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
Yes

Inclusion criteria

  • Age 18 or older
  • Current cigarette smoker
  • Having an iPhone 6s or higher
  • Willing and able to download a mobile app
  • Able to read and speak English
  • Having an upcoming appointment with a participating clinician in the next 42 days

Exclusion criteria

Exclusion Criteria:

  • Younger than 18
  • Non-smoker
  • Unable to read and speak English
  • Not having an iPhone 6s or higher
  • Not having an appointment with a participating clinician in the next 42 days
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrollment
51 participants (actual)

Study arms

  • Experimental
    App users

    All participants will be provided with access to the intervention app (refresh).

    Behavioral: refresh

Interventions

  • Behavioralrefresh

    A theoretically-grounded, highly individualized tobacco cessation Health-Kit enabled app. Unlike existing tobacco cessation apps, refresh: 1) implements a full range of best practices in tailored health behavior change communications; 2) individualizes messaging based on the patient's clinical context using Health app data obtained through Fast Healthcare Interoperability Resources (FHIR) standard Application Programming Interfaces (API) and behavior change constructs; and 3) provides data and key insights back to the EHR.

06

What researchers measure

Primary outcomes

  1. Psychosocial Expectancies (PROMIS Smoking Initiative) Patient Reported Outcome

    This reliable and valid 6-item assessment measures feelings of social disapproval of smoking, normative values associated with smoking, and negative beliefs about appearance when smoking (e.g., If I quit smoking I will be more in control of my life). It will be the primary outcome as it is appropriate for all smokers (ready to quit or not) and is highly correlated with interest in quitting (r=0.59). It is also correlated with recency of quit attempts. Participants respond on a 5-point Likert Scale from 0 (Not at all) to 4 (Very much). Raw scores range from a minimum of 0 to a maximum of 24, with higher scores indicating better outcomes. The reliability of the scale is 0.85.

    Time frame: Pretest (baseline) and Posttest (30 day follow-up)

Secondary outcomes

  1. Confidence

    This 3-item scale assesses an individual's confidence level to refrain from using tobacco even in difficult situations and is a leading indicator of movement to cessation. Ratings of confidence will be made on a 5-point Likert scale (1=not at all; 5=extremely confident). Raw scores range from a minimum of 3 to a maximum of 15, with higher scores indicating better outcomes.

    Time frame: Pretest (baseline) and Posttest (30 day follow-up)

07

Results

Posted Feb 13, 2025

Participant flow

Participant flow — Overall Study
MilestoneApp Users
Started51
Completed39
Not completed12

Outcome measures

PrimaryPsychosocial Expectancies (PROMIS Smoking Initiative) Patient Reported Outcome

This reliable and valid 6-item assessment measures feelings of social disapproval of smoking, normative values associated with smoking, and negative beliefs about appearance when smoking (e.g., If I quit smoking I will be more in control of my life). It will be the primary outcome as it is appropriate for all smokers (ready to quit or not) and is highly correlated with interest in quitting (r=0.59). It is also correlated with recency of quit attempts. Participants respond on a 5-point Likert Scale from 0 (Not at all) to 4 (Very much). Raw scores range from a minimum of 0 to a maximum of 24, with higher scores indicating better outcomes. The reliability of the scale is 0.85.

Time frame:
Pretest (baseline) and Posttest (30 day follow-up)
Reported as:
Mean · score on a scale
Psychosocial Expectancies (PROMIS Smoking Initiative) Patient Reported Outcome
score on a scaleApp Users
Pretest (baseline)12.7 ± 6.8
Posttest (30 day follow-up)13.6 ± 5.6
Statistical analysis
  • App Users · t-test, 2 sided · p = 0.17
SecondaryConfidence

This 3-item scale assesses an individual's confidence level to refrain from using tobacco even in difficult situations and is a leading indicator of movement to cessation. Ratings of confidence will be made on a 5-point Likert scale (1=not at all; 5=extremely confident). Raw scores range from a minimum of 3 to a maximum of 15, with higher scores indicating better outcomes.

Time frame:
Pretest (baseline) and Posttest (30 day follow-up)
Reported as:
Mean · score on a scale
Confidence
score on a scaleApp Users
Pretest (baseline)6.3 ± 2.5
Posttest (30 day follow-up)7.6 ± 2.7
Statistical analysis
  • App Users · t-test, 2 sided · p = 0.006

Adverse events

Collected over 30 days. Non-serious events are listed at a 0% frequency threshold.

Adverse event summary by group
GroupDeathsSeriousOther
App Users0/51 (0%)0/51 (0%)0/51 (0%)

Baseline characteristics

Age, Categorical
Age, Categorical(Participants)App Users
<=18 years0
Between 18 and 65 years49
>=65 years2
Age, Continuous
Age, Continuous(years)App Users
Mean47.4 ± 11.3
Sex: Female, Male
Sex: Female, Male(Participants)App Users
Female38
Male13
Ethnicity (NIH/OMB)
Ethnicity (NIH/OMB)(Participants)App Users
Hispanic or Latino8
Not Hispanic or Latino43
Unknown or Not Reported0
Race (NIH/OMB)
Race (NIH/OMB)(Participants)App Users
American Indian or Alaska Native1
Asian1
Native Hawaiian or Other Pacific Islander0
Black or African American24
White18
More than one race2
Unknown or Not Reported5
Region of Enrollment
Region of Enrollment(participants)App Users
United States51
08

Study locations

1 site
  • Pro-Change Behavior Systems, Inc
    South Kingstown, Rhode Island 02879, United States
09

References and documents

Study documents

  • Study protocol · Dec 15, 2024
  • Statistical analysis plan · Dec 15, 2024
  • Informed consent form · Apr 11, 2023

Documents are hosted by the registry — open the source record to download them.

Individual participant data

Plan to share: No — A variety of peer-reviewed publications will emerge from the proposed research. At the conclusion of the study, the data will be de-identified and then made available to those requesting access, provided that they sign an agreement that the data will be used for research purposes only. Pro-Change routinely asks those requesting access to any data to sign such a form.

10

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on May 16, 2025, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
11

Registry details

Key details

Study ID
NCT06292130
Lead sponsor
Pro-Change Behavior Systems
Collaborators
National Heart, Lung, and Blood Institute (NHLBI)
Responsible party
Sara Johnson (Co-President & CEO, Pro-Change Behavior Systems) — Principal investigator
First posted
Mar 4, 2024
Start date
Mar 21, 2022
Primary completion
Sep 21, 2023
Completion
Sep 21, 2023
Results posted
Feb 13, 2025
Last update
May 16, 2025

Study contacts

Sara Johnson, Ph.D.
principal investigator · Pro-Change Behavior Systems, Inc.

Oversight

Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in May 2025. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion